Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid versus linezolid in drug-sensitive and multidrug-resistant pulmonary tuberculosis
ChiCTR2100053968Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of contezolid and linezolid in pulmonary tuberculosis (TB) (2 cohorts), sponsored by Shanghai Pulmonary Hospital. Primary endpoints: Blood routine, Visual acuity and 2 more. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
contezolidlinezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2100053968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053968.